Provided by Tiger Trade Technology Pte. Ltd.

Bone Biologics Corp

0.5600
-0.0010-0.18%
Volume:3K
Turnover:1.77K
Market Cap:1.54M
PE:-0.35
High:0.5625
Open:0.5608
Low:0.5600
Close:0.5610
52wk High:2.89
52wk Low:0.5402
Shares:2.76M
Float Shares:2.76M
Volume Ratio:0.17
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6080
EPS(LYR):-2.6500
ROE:-54.96%
ROA:-33.46%
PB:0.39
PE(LYR):-0.21

Loading ...

Mar 30, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 29, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 21, 2022

Major Issues Report

8-K - Current report
Nov 21, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 25, 2022

Major Issues Report

8-K - Current report
Oct 13, 2022

Major Issues Report

8-K - Current report
Oct 12, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 11, 2022

Major Issues Report

8-K - Current report
Oct 05, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 04, 2022

Correspondence

CORRESP [Cover] - Correspondence
Oct 04, 2022

Correspondence

CORRESP [Cover] - Correspondence
Oct 04, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 23, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Aug 24, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 07, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jun 09, 2022

Major Issues Report

8-K - Current report